1 |
Ransom CB, Sontheimer H. BK channels in human glioma cells. J Neurophysiol. 2001;85:790-803.
DOI
|
2 |
Basrai D, Kraft R, Bollensdorff C, Liebmann L, Benndorf K, Patt S. BK channel blockers inhibit potassium-induced proliferation of human astrocytoma cells. Neuroreport. 2002;13:403-407.
DOI
ScienceOn
|
3 |
Weaver AK, Bomben VC, Sontheimer H. Expression and function of calcium-activated potassium channels in human glioma cells. Glia. 2006;54:223-233.
DOI
ScienceOn
|
4 |
Coiret G, Borowiec AS, Mariot P, Ouadid-Ahidouch H, Matifat F. The antiestrogen tamoxifen activates BK channels and stimulates proliferation of MCF-7 breast cancer cells. Mol Pharmacol. 2007;71:843-851.
|
5 |
Bloch M, Ousingsawat J, Simon R, Schraml P, Gasser TC, Mihatsch MJ, Kunzelmann K, Bubendorf L. KCNMA1 gene amplification promotes tumor cell proliferation in human prostate cancer. Oncogene. 2007;26:2525-2534.
DOI
ScienceOn
|
6 |
Wang Z. Roles of channels in regulating tumour cell proliferation and apoptosis. Pflugers Arch. 2004;448:274-286.
DOI
ScienceOn
|
7 |
Kuhlmann CR, Schaefer CA, Kosok C, Abdallah Y, Walther S, Ludders DW, Neumann T, Tillmanns H, Schafer C, Piper HM, Erdogan A. Quercetin-induced induction of the NO/cGMP pathway depends on -activated channel-induced hyperpolarization- mediated -entry into cultured human endothelial cells. Planta Med. 2005;71:520-524.
DOI
ScienceOn
|
8 |
Saponara S, Sgaragli G, Fusi F. Quercetin as a novel activator of L-type channels in rat tail artery smooth muscle cells. Br J Pharmacol. 2002;135:1819-1827
DOI
ScienceOn
|
9 |
Saponara S, Sgaragli G, Fusi F. Quercetin antagonism of Bay K 8644 effects on rat tail artery L-type channels. Eur J Pharmacol. 2008;598:75-80.
DOI
|
10 |
Nishida S, Satoh H. Possible Involvement of Ca activated K channels, SK channel, in the quercetin-induced vasodilatation. Korean J Physiol Pharmacol. 2009;13:361-365
DOI
|
11 |
Yang L, Ma JH, Zhang PH, Zou AR, Tu DN. Quercetin activates human Kv1.5 channels by a residue I502 in the S6 segment. Clin Exp Pharmacol Physiol. 2009;36:154-161.
DOI
ScienceOn
|
12 |
Pyle LC, Fulton JC, Sloane PA, Backer K, Mazur M, Prasain J, Barnes S, Clancy JP, Rowe SM. Activation of the cystic fibrosis transmembrane conductance regulator by the flavonoid quercetin: potential use as a biomarker of cystic fibrosis transmembrane conductance regulator rescue. Am J Respir Cell Mol Biol. 2010;43:607-616.
DOI
ScienceOn
|
13 |
Lee BH, Hwang SH, Choi SH, Shin TJ, Kang J, Lee SM, Nah SY. Quercetin Inhibits Nicotinic acetylcholine receptormediated ion currents expressed in Xenopus oocytes. Korean J Physiol Pharmacol. 2011;15:17-22.
DOI
|
14 |
Hirpara KV, Aggarwal P, Mukherjee AJ, Joshi N, Burman AC. Quercetin and its derivatives: synthesis, pharmacological uses with special emphasis on anti-tumor properties and prodrug with enhanced bio-availability. Anticancer Agents Med Chem. 2009;9:138-161
DOI
ScienceOn
|
15 |
Ouadid-Ahidouch H, Roudbaraki M, Ahidouch A, Delcourt P, Prevarskaya N. Cell-cycle-dependent expression of the large -activated channels in breast cancer cells. Biochem Biophys Res Commun. 2004;316:244-251.
DOI
ScienceOn
|
16 |
Han X, Xi L, Wang H, Huang X, Ma X, Han Z, Wu P, Ma X, Lu Y, Wang G, Zhou J, Ma D. The potassium ion channel opener NS1619 inhibits proliferation and induces apoptosis in A2780 ovarian cancer cells. Biochem Biophys Res Commun. 2008;375:205-209.
DOI
ScienceOn
|
17 |
Cambien B, Rezzonico R, Vitale S, Rouzaire-Dubois B, Dubois JM, Barthel R, Karimdjee BS, Mograbi B, Schmid-Alliana A, Schmid-Antomarchi H. Silencing of hSlo potassium channels in human osteosarcoma cells promotes tumorigenesis. Int J Cancer. 2008;123:365-371.
DOI
ScienceOn
|
18 |
Abdullaev IF, Rudkouskaya A, Mongin AA, Kuo YH. Calciumactivated potassium channels BK and IK1 are functionally expressed in human gliomas but do not regulate cell proliferation. PLoS One. 2010;5:e12304
DOI
|
19 |
Roger S, Potier M, Vandier C, Le Guennec JY, Besson P. Description and role in proliferation of iberiotoxin-sensitive currents in different human mammary epithelial normal and cancerous cells. Biochim Biophys Acta. 2004;1667:190-199.
DOI
ScienceOn
|
20 |
Ma L, Feugang JM, Konarski P, Wang J, Lu J, Fu S, Ma B, Tian B, Zou C, Wang Z. Growth inhibitory effects of quercetin on bladder cancer cell. Front Biosci. 2006;11:2275-2285
DOI
ScienceOn
|
21 |
Okamoto T. Safety of quercetin for clinical application (Review). Int J Mol Med. 2005;16:275-278.
|
22 |
Ruiz MJ, Fernandez M, Pico Y, Manes J, Asensi M, Carda C, Asensio G, Estrela JM. Dietary administration of high doses of pterostilbene and quercetin to mice is not toxic. J Agric Food Chem. 2009;57:3180-3186.
DOI
ScienceOn
|
23 |
Avila MA, Velasco JA, Cansado J, Notario V. Quercetin mediates the down-regulation of mutant p53 in the human breast cancer cell line MDA-MB468. Cancer Res. 1994;54:2424-2428.
|
24 |
Kim HJ, Kim SK, Kim BS, Lee SH, Park YS, Park BK, Kim SJ, Kim J, Choi C, Kim JS, Cho SD, Jung JW, Roh KH, Kang KS, Jung JY. Apoptotic effect of quercetin on HT-29 colon cancer cells via the AMPK signaling pathway. J Agric Food Chem. 2010;58:8643-8650.
DOI
ScienceOn
|
25 |
Wang HY, Guo LM, Chen Y, Zhao XH, Cheng CL, Wu MY, He LY. Quercetin inhibits growth and induces apoptosis of human gastric carcinoma cells. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2006;22:585-587.
|
26 |
Monasterio A, Urdaci MC, Pinchuk IV, Lopez-Moratalla N, Martinez-Irujo JJ. Flavonoids induce apoptosis in human leukemia U937 cells through caspase- and caspase-calpaindependent pathways. Nutr Cancer. 2004;50:90-100
DOI
ScienceOn
|
27 |
Beniston RG, Campo MS. Quercetin elevates p27 and arrests both primary and HPV16 E6/E7 transformed human keratinocytes in G1. Oncogene. 2003;22:5504-5514.
DOI
ScienceOn
|
28 |
Zhang M, Swarts SG, Yin L, Liu C, Tian Y, Cao Y, Swarts M, Yang S, Zhang SB, Zhang K, Ju S, Olek DJ Jr, Schwartz L, Keng PC, Howell R, Zhang L, Okunieff P. Antioxidant properties of quercetin. Adv Exp Med Biol. 2011;701:283-289.
|
29 |
Moon SK, Cho GO, Jung SY, Gal SW, Kwon TK, Lee YC, Madamanchi NR, Kim CH. Quercetin exerts multiple inhibitory effects on vascular smooth muscle cells: role of ERK1/2, cellcycle regulation, and matrix metalloproteinase-9. Biochem Biophys Res Commun. 2003;301:1069-78.
DOI
ScienceOn
|
30 |
Choi JA, Kim JY, Lee JY, Kang CM, Kwon HJ, Yoo YD, Kim TW, Lee YS, Lee SJ. Induction of cell cycle arrest and apoptosis in human breast cancer cells by quercetin. Int J Oncol. 2001;19:837-844.
|
31 |
Mittra B, Saha A, Chowdhury AR, Pal C, Mandal S, Mukhopadhyay S, Bandyopadhyay S, Majumder HK. Luteolin, an abundant dietary component is a potent anti-leishmanial agent that acts by inducing topoisomerase II-mediated kinetoplast DNA cleavage leading to apoptosis. Mol Med. 2000;6:527-541.
DOI
ScienceOn
|
32 |
Vidya Priyadarsini R, Senthil Murugan R, Maitreyi S, Ramalingam K, Karunagaran D, Nagini S. The flavonoid quercetin induces cell cycle arrest and mitochondria-mediated apoptosis in human cervical cancer (HeLa) cells through p53 induction and inhibition. Eur J Pharmacol. 2010;649:84-91.
DOI
ScienceOn
|
33 |
Huang MH, Wu SN, Chen CP, Shen AY. Inhibition of - activated and voltage-dependent currents by 2-mercaptophenyl- 1,4-naphthoquinone in pituitary GH3 cells: contribution to its antiproliferative effect. Life Sci. 2002;70:1185-1203.
DOI
ScienceOn
|
34 |
Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch. 1981;391:85-100.
DOI
ScienceOn
|
35 |
Yamada A, Gaja N, Ohya S, Muraki K, Narita H, Ohwada T, Imaizumi Y. Usefulness and limitation of , a voltage-sensitive fluorescent dye, for the measurement of membrane potentials regulated by recombinant large conductance -activated channels in HEK293 cells. Jpn J Pharmacol. 2001;86:342-350.
DOI
|
36 |
Lang F, Foller M, Lang K, Lang P, Ritter M, Vereninov A, Szabo I, Huber SM, Gulbins E. Cell volume regulatory ion channels in cell proliferation and cell death. Methods Enzymol. 2007;428:209-225.
|
37 |
Lockyer CR, Gillatt DA. BCG immunotherapy for superficial bladder cancer. J R Soc Med. 2001;94:119-123.
DOI
|
38 |
Kakehi Y, Hirao Y, Kim WJ, Ozono S, Masumori N, Miyanaga N, Nasu Y, Yokomizo A. Bladder Cancer Working Group report. Jpn J Clin Oncol. 2010;40 Suppl 1:i57-64.
DOI
|
39 |
Shang PF, Kwong J, Wang ZP, Tian J, Jiang L, Yang K, Yue ZJ, Tian JQ. Intravesical Bacillus Calmette-Guerin versus epirubicin for Ta and T1 bladder cancer. Cochrane Database Syst Rev. 2011;(5):CD006885.
|
40 |
Friberg S. BCG in the treatment of superficial cancer of the bladder: a review. Med Oncol Tumor Pharmacother. 1993;10:31-36.
|